Canopy Growth Corp Financing Receivable, Past Due
Canopy Growth Corp (CGC) had Financing Receivable, Past Due of CAD 7.21 million as of 2020-12-31, per its 10-Q filed 2021-02-09.
Discontinued › Notes › Receivables
us-gaap:FinancingReceivableRecordedInvestmentPastDue · last filed 2021-02-09
- 2020-12-31: Financing Receivable, Past Due 7.21M CAD.
| Period end | Financing Receivable, Past Due |
|---|---|
| 2020-12-31 | 7.21M CAD 10-Q · filed 2021-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |